Cellaria Inc. launches new cell lines to support the development of personalized therapies for lung cancer
The cell lines offer researchers a diverse cohort of patient specific models to accelerate drug development
The cell lines offer researchers a diverse cohort of patient specific models to accelerate drug development
Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions
New application notes, videos and products
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
The autonomous cellufacturing facility aims to enable continuously scalable, cost-effective, automated food scale production of cell cultured human milk
First in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening
Find out how a pioneering precision medicine company is using cell counting technology to improve patient outcomes
Innovation and growth remain a priority to support customers and COVID-19 initiatives
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies